Therapeutic Antibodies against Virus Infection

Dear Colleagues,

Therapeutic monoclonal antibodies (mAbs) have become one of the fastest-growing classes of drugs in recent years and are approved for the treatment of a wide range of indications, including virus infections. Mabs and polyclonal antibodies are used for pre-exposure prophylaxis (Prep), post-exposure prophylaxis (PEP), and treatment of viral infections such as rabies, hepatitis B, SARS-CoV-2, RSV, and others.

Commonly, antibody-based immunotherapies are well-tolerated, highly specific, and thus potent tools to protect from infection or a severe course of disease.

Development, characterization, and pre-clinical or clinical evaluation of novel antiviral mAbs that can protect from disease is important, and articles on this topic are welcome.

Dr. Adalbert Krawczyk
Dr. Matthias Zehner
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.